MeMed
PrivateLast Round
VC Round
Jan 10, 2022
Total Funding Raised
$98.03M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
MeMed is a healthcare technology company that develops immuno-personalized diagnostic devices to rapidly identify bacterial and viral infections by analyzing patients' immune responses, thereby assisting physicians in making informed antibiotic treatment decisions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MeMed Comparables
Compare MeMed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inflammatix | 91% | |
| Lumos Diagnostics Holdings Limited | 82% | |
| Biomeme | 81% | |
MeMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 10, 2022 | ||||
| Grant | Nov 13, 2019 | ||||
| Series C | Sep 20, 2018 | ||||
| Grant | Feb 6, 2018 | ||||
| Grant | Apr 19, 2017 | ||||
Grant | Sep 18, 2015 |
Key People
Founding team and executive leadership
MeMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series B, Series C, VC Round |
| European Innovation Council Fund | Grant |
| Union Tech Ventures | VC Round |
| European Commission (Horizon Europe) | Grant |
| Clal Insurance | Series C |
| S28 Capital | Series C |
| Touchwood Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 62% MoM.
- Mar 1, 2026
Developing a next-generation AIVD product.
MeMed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MeMed's valuation, stock price, and market status.